These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 24655813)

  • 1. Cognitive dysfunction after chemotherapy for breast cancer.
    Edelstein K; Bernstein LJ
    J Int Neuropsychol Soc; 2014 Apr; 20(4):351-6. PubMed ID: 24655813
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant chemotherapy and cognitive dysfunction in breast cancer patients.
    J Support Oncol; 2006 Feb; 4(2):66-7. PubMed ID: 16499119
    [No Abstract]   [Full Text] [Related]  

  • 3. Cognitive side-effects of adjuvant treatments.
    Burstein HJ
    Breast; 2007 Dec; 16 Suppl 2():S166-8. PubMed ID: 17719225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive adverse effects of chemotherapy in breast cancer patients.
    Correa DD; Ahles TA
    Curr Opin Support Palliat Care; 2007 Apr; 1(1):57-62. PubMed ID: 18660726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive decline in breast cancer patients.
    Health News; 2004 Nov; 10(11):9. PubMed ID: 15655856
    [No Abstract]   [Full Text] [Related]  

  • 6. Neurocognitive effects of chemotherapy and endocrine therapies in the treatment of breast cancer: recent perspectives.
    Walker CH; Drew BA; Antoon JW; Kalueff AV; Beckman BS
    Cancer Invest; 2012 Feb; 30(2):135-48. PubMed ID: 22250588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurocognitive changes in cancer survivors.
    Correa DD; Ahles TA
    Cancer J; 2008; 14(6):396-400. PubMed ID: 19060604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer and "chemobrain": the consequences of cognitive difficulties following chemotherapy and the potential for recovery.
    Reid-Arndt SA
    Mo Med; 2009; 106(2):127-31. PubMed ID: 19397112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients.
    Schagen SB; Muller MJ; Boogerd W; Mellenbergh GJ; van Dam FS
    J Natl Cancer Inst; 2006 Dec; 98(23):1742-5. PubMed ID: 17148777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer treatment and cognitive functioning: current status and future challenges in assessment.
    Castellon SA; Silverman DH; Ganz PA
    Breast Cancer Res Treat; 2005 Aug; 92(3):199-206. PubMed ID: 16155790
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical practice guidelines for the care and treatment of breast cancer: follow-up after treatment for breast cancer (summary of the 2005 update).
    Grunfeld E; Dhesy-Thind S; Levine M;
    CMAJ; 2005 May; 172(10):1319-20. PubMed ID: 15883407
    [No Abstract]   [Full Text] [Related]  

  • 12. Acupuncture for chemotherapy-associated cognitive dysfunction: a hypothesis-generating literature review to inform clinical advice.
    Johnston MF; Yang C; Hui KK; Xiao B; Li XS; Rusiewicz A
    Integr Cancer Ther; 2007 Mar; 6(1):36-41. PubMed ID: 17351025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A meta-analysis of the sensitivity of various neuropsychological tests used to detect chemotherapy-induced cognitive impairment in patients with breast cancer.
    Jansen CE; Miaskowski CA; Dodd MJ; Dowling GA
    Oncol Nurs Forum; 2007 Sep; 34(5):997-1005. PubMed ID: 17878128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy, neurotoxicity, and cognitive changes in breast cancer.
    Dutta V
    J Cancer Res Ther; 2011; 7(3):264-9. PubMed ID: 22044805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide.
    Jansen CE; Dodd MJ; Miaskowski CA; Dowling GA; Kramer J
    Psychooncology; 2008 Dec; 17(12):1189-95. PubMed ID: 18506671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychostimulants for chemotherapy induced cognitive changes in cancer, Ockham's razor, anyone?
    Dutta V
    J Cancer Res Ther; 2012; 8(2):326-9. PubMed ID: 22842390
    [No Abstract]   [Full Text] [Related]  

  • 17. Objective and self-reported cognitive dysfunction in breast cancer women treated with chemotherapy: a prospective study.
    Biglia N; Bounous VE; Malabaila A; Palmisano D; Torta DM; D'Alonzo M; Sismondi P; Torta R
    Eur J Cancer Care (Engl); 2012 Jul; 21(4):485-92. PubMed ID: 22211832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive function, fatigue, and menopausal symptoms in breast cancer patients receiving adjuvant chemotherapy: evaluation with patient interview after formal assessment.
    Downie FP; Mar Fan HG; Houédé-Tchen N; Yi Q; Tannock IF
    Psychooncology; 2006 Oct; 15(10):921-30. PubMed ID: 16477674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neurobiological basis of anti-cancer therapy induced cognitive dysfunction and the promising pharmacological modalities against the same.
    Revannasiddaiah S; Gupta M; Seam R; Gupta M
    J Cancer Res Ther; 2012; 8(1):162-3. PubMed ID: 22531545
    [No Abstract]   [Full Text] [Related]  

  • 20. Cognitive dysfunction following adjuvant chemotherapy for breast cancer: two case studies.
    Paraska K; Bender CM
    Oncol Nurs Forum; 2003; 30(3):473-8. PubMed ID: 12719746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.